DEADLINE

• Abstracts must be submitted by September 16, 2026
• Authors can edit their abstracts until the submission deadline. No further changes will be accepted after the date
• The committee reserves the right to extend or shorten the date of abstract submission.

SUBMISSION

• Abstracts received not following the standard formats will not be accepted.
• For any issues with the online submission platform, please contact the event coordinator above.

ACKNOWLEDGEMENT

• Abstract submission will be acknowledged via email. If there is no acknowledgement received within a week of the submission or if you have any additional queries, please contact Ms. Zandy at zandy@menaconference.com

NOTIFICATION OF RESULTS

• All ACCEPTED abstracts will be notified via email on September 30, 2026.
• The email will contain information on acceptance or rejection of abstract.
• For accepted oral presenters, the date and time of the assigned session will be communicated to you as soon as the committee has finalized the agenda.

LANGUAGE

• All documents must be submitted and presented in English.
• It is the author’s responsibility to submit the correct abstract (grammatically and scientifically)

TYPE OF PRESENTATION

• Accepted abstracts may be scheduled for either oral or poster presentation. The final presentation format is at the discretion of the Abstract Review Committee

ABSTRACT SPECIFICS

• A maximum of 2 abstracts can be submitted per author

1. Information Content:

Abstracts must be sufficiently informative to allow reviewers a comprehensive evaluation of the study's key aspects:

• Topic: The abstract should clearly define the research area and its significance within the broader field.
• Methodology: The chosen investigative technique and its suitability for addressing the stated research question must be explicitly justified.
• Results: The abstract should summarize the primary findings of the study, emphasizing original data gathered by the author(s).
• Conclusions: The main inferences drawn from the results and their implications should be concisely presented.

2. Focus on Outcomes:

The abstract's primary function is to present the substantive outcomes of the work, not merely enumerate potential avenues of inquiry. It should serve as a concise yet informative prelude to the full study.

3. Data Originality:

Only original scientific data obtained by the author(s) is acceptable for inclusion in the abstract. All submitted reports must be based on completed research; "in progress" studies will not be considered.

4. Professional Conduct:

Presenters are expected to utilize their allocated session solely for scientific discourse and refrain from any form of product, service, or personal promotion.

AUTHOR & PRESENTER INFORMATION

• Assigning the delegated presenter should be in agreement with other authors

• Only one presenter is allowed to present the abstract. Kindly make note of this for abstracts with multiple authors

SPECIFY IN THE ABSTRACT DETAILS BOX IF YOU ARE THE PRINCIPAL OR A CO-AUTHOR.

The selected abstract / presenter will receive:

• • Complimentary registration at the conference
  • Certificate of attendance (CME certificate)
  • Appreciation certification for presenting at the conference

ABSTRACT SELECTION PROCESS

• Criteria will include uniqueness of case, appropriateness of methods, interpretation and presentation of results, overall clarity

ABSTRACT DETAILS (400 words maximum excluding references)

1. Introduction / Background
2. Objectives
3. Methods (if a clinical case, include diagnostic evaluation, treatment and follow-up)
4. Results
5. Conclusion(s)
6. References

DCT Documents

photo
[white background preferably]

Passport copy
[with Unified ID no. for Emiratis]

DCT Speaker/Presenter permit form

Emirates ID

UAE residence visa

International

YES

YES

YES

N/A

N/A

UAE

YES

YES

N/A

YES

YES